← Leaderboards
Jong Y Park
H. Lee Moffitt Cancer Ctr & Res Inst
$3,295,954
Attributed
$3,295,954
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $628.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,295,954 · 5
By mechanism
R01$2,037,398 · 1
U54$524,167 · 1
R21$428,529 · 1
R03$305,860 · 2
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Conor C Lynch$9,082,731
- John L. Cleveland$27,832,236
- David Basanta Gutierrez$3,082,070
- Matthew B. Schabath$5,397,368
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateCancer PatientGenesProstateTissuesTumorPlayCancer CenterMethylationDna MethylationMolecularGeneticRaceProstatic NeoplasmsRecurrenceBiologicalPathway InteractionsNeoplasm RegistryOperative Surgical ProceduresBaseCohortEpigenetic ProcessGenotypeVariant
Grant awards (14)
Project 1: Epigenetic variations associated with aggressiveness in prostate cancer among Puerto Rican men$147,264
U54 · FY2025 · CA · contact PI
Project 1: Epigenetic variations associated with aggressiveness in prostate cancer among Puerto Rican men$184,602
U54 · FY2024 · CA · contact PI
The ODC A allele as a driver and therapeutic target of aggressive prostate cancer in African American men$231,595
R21 · FY2023 · CA · contact PI
Project 1: Epigenetic variations associated with aggressiveness in prostate cancer among Puerto Rican men$192,301
U54 · FY2023 · CA · contact PI
The ODC A allele as a driver and therapeutic target of aggressive prostate cancer in African American men$196,934
R21 · FY2022 · CA · contact PI
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer$327,253
R01 · FY2012 · CA · contact PI
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer$463,861
R01 · FY2011 · CA · contact PI
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer$1
R01 · FY2010 · CA · contact PI
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer$628,729
R01 · FY2009 · CA · contact PI
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer$617,554
R01 · FY2008 · CA · contact PI
Epigenetic Markers for Lung Cancer Detection$79,585
R03 · FY2006 · CA · contact PI
Epigenetic Markers for Lung Cancer Detection$81,500
R03 · FY2005 · CA
Elucidation of epoxide hydrolase polymorphisms$72,500
R03 · FY2002 · CA
Elucidation of epoxide hydrolase polymorphisms$72,275
R03 · FY2001 · CA